SIGVARIS Group Acquires the American Company BiaCare
With the acquisition of BiaCare, the SIGVARIS Group further strengthens its position in a rapidly growing market. BiaCare is renowned for its high medical standards and enjoys the trust of many physicians and therapists. “This transaction allows us to acquire an established manufacturer with a strong position in the US market. BiaCare’s innovative line of compression products designed to treat lymphedema, lipedema, chronic venous insufficiency and other complex edemas immediately broadens the SIGVARIS offering.” says Urs H. Toedtli, CEO of the SIGVARIS Group.
Scot Dubé, President & CEO North America, is pleased about the strengthened market position and the opportunities that arise from it. “By sharing our know-how, we create a platform with growth potential in the US market and offer a more therapeutic medical product offering, strengthening our position as a solution provider for medical professionals and patients.”
The Swiss Group SIGVARIS has its headquarters in Switzerland and is the global market leader in the manufacture of medical compression garments. It employs about 1,500 people and has its own production plants in Switzerland, France, Poland, the US and Brazil. SIGVARIS is close to its customers, having subsidiaries in Germany, Austria, England, Italy, Canada, China, Australia, Mexico and the United Arab Emirates as well as distributors in more than 70 countries on all continents. The Group pursues an international growth strategy on the solid foundation of more than 150 years of success.
BiaCare is based in Zeeland, Michigan, U.S., and has been manufacturing products for veno-lymphatic patients for 12 years. The company has developed a reputation for being an innovative leader in the design and production of short stretch velcro wraps as well as day and night garments for lymphedema and lipedema patients. BiaCare employs 22 people in its Zeeland, MI location. www.biacare.com